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Abstract: No reliable non-invasive glucose monitoring devices are cur-
rently available. We implemented a mid-infrared (MIR) photoacoustic (PA)
setup to track glucose in vitro in deep epidermal layers, which represents a
signiﬁcant step towards non-invasive in vivo glucose measurements using
MIR light. An external-cavity quantum-cascade laser (1010-1095 cm−1)
and a PA cell of only 78 mm3 volume were employed to monitor glucose
in epidermal skin. Skin samples are characterized by a high water content.
Such samples investigated with an open-ended PA cell lead to varying
conditions in the PA chamber (i.e., change of light absorption or relative
humidity) and cause unstable signals. To circumvent variations in relative
humidity and possible water condensation, the PA chamber was constantly
ventilated by a 10 sccm N2 ﬂow. By bringing the epidermal skin samples
in contact with aqueous glucose solutions with different concentrations
(i.e., 0.1-10 g/dl), the glucose concentration in the skin sample was varied
through passive diffusion. The achieved detection limit for glucose in
epidermal skin is 100 mg/dl (SNR=1). Although this lies within the human
physiological range (30-500 mg/dl) further improvements are necessary
to non-invasively monitor glucose levels of diabetes patients. Furthermore
spectra of epidermal tissue with and without glucose content have been
recorded with the tunable quantum-cascade laser, indicating that epidermal
constituents do not impair glucose detection.
© 2012 Optical Society of America
OCIS codes: (110.5125) Photoacoustics; (140.5965) Semiconductor laser, quantum cascade;
(170.1470) Blood or tissue constituent monitoring; (170.6510) Spectroscopy, tissue diagnos-
tics.
References and links
1. WHO, “Diabetes,” http://www.who.int/mediacentre/factsheets/fs312/en/.
2. E. Renard, “Monitoring glycemic control: the importance of self-monitoring of blood glucose,” Am. J. Med. 118,
12S–19S (2005).
3. C. E. F. do Amaral and B. Wolf, “Current development in non-invasive glucose monitoring,” Med. Eng. Phys.
30, 541–549 (2008).
4. O. S. Khalil, “Spectroscopic and clinical aspects of noninvasive glucose measurements,” Clin. Chem. 45, 165–
177 (1999).
#161280 - $15.00 USD Received 11 Jan 2012; revised 16 Feb 2012; accepted 17 Feb 2012; published 1 Mar 2012
(C) 2012 OSA 1 April 2012 / Vol. 3,  No. 4 / BIOMEDICAL OPTICS EXPRESS  6675. O. S. Khalil, “Non-invasive glucose measurement technologies: An update from 1999 to the dawn of the millen-
nium,” Diabetes Technol. Ther. 6, 660–697 (2004).
6. R. J. McNichols and G. L. Cot´ e, “Optical glucose sensing in biological ﬂuids: an overview,” J. Biomed. Opt. 5,
5–16 (2000).
7. C. Chou, C. Han, W. Kuo, Y. Huang, C. Feng, and J. Shyu, “Noninvasive glucose monitoring in vivo with an
optical heterodyne polarimeter,” Appl. Opt. 37, 3553–3557 (1998).
8. B. H. Malik, “Real-time, closed-loop dual-wavelength optical polarimetry for glucose monitoring,” J. Biomed.
Opt. 15, 017002 (2010).
9. A. M. K. Enejder, T. G. Scecina, J. Oh, M. Hunter, W. Shih, S. Sasic, G. L. Horowitz, and M. S. Feld, “Raman
spectroscopy for noninvasive glucose measurements,” J. Biomed. Opt. 10, 031114 (2005).
10. J. L. Lambert, C. C. Pelletier, and M. Borchert, “Glucose determination in human aqueous humor with Raman
spectroscopy,” J. Biomed. Opt. 10, 031110 (2005).
11. R. Marbach, T. Koschinsky, F. A. Gries, and H. M. Heise, “Noninvasive blood glucose assay by near-infrared
diffuse reﬂectance spectroscopy of the human inner lip,” Appl. Spectrosc. 47, 875–881 (1993).
12. K. Maruo, M. Tsurugi, M. Tamura, and Y. Ozaki, “In vivo noninvasive measurement of blood glucose by near-
infrared diffuse-reﬂectance spectroscopy,” Appl. Spectrosc. 57, 1236–1244 (2003).
13. C. Vrancic, A. Fomichova, N. Gretz, C. Herrmann, S. Neudecker, A. Pucci, and W. Petrich, “Continuous glucose
monitoring by means of mid-infrared transmission laser spectroscopy in vitro,” Analyst 136, 1192–1198 (2011).
14. I. Gabriely, R. Wozniak, M. Mevorach, J. Kaplan, Y. Aharon, and H. Shamoon, “Transcutaneous glucose
measurement using near-infrared spectroscopy during hypoglycemia,” Diabetes Care 22, 2026–2032 (1999).
15. G. Spanner and R. Niessner, “New concept for the non-invasive determination of physiological glucose concen-
trations using modulated laser diodes.” Fresenius J. Anal. Chem. 355, 327–328 (1996).
16. C. D. Malchoff, K. Shoukri, J. I. Landau, and J. M. Buchert, “A novel noninvasive blood glucose monitor,”
Diabetes Care 25, 2268–2275 (2002).
17. X. Guo, A. Mandelis, A. Matvienko, K. Sivagurunathan, and B. Zinman, “Wavelength-modulated differential
laser photothermal radiometry for blood glucose measurements,” J. Phys. Conf. Ser. 214, 012025 (2010).
18. R. Ballerstadt, C. Evans, A. Gowda, and R. McNichols, “In vivo performance evaluation of a transdermal near-
infrared ﬂuorescence resonance energy transfer afﬁnity sensor for continuous glucose monitoring,” Diabetes
Technol. Ther. 8, 296–311 (2006).
19. W.March,D.Lazzaro,andS.Rastogi,“Fluorescentmeasurementinthenon-invasicecontactlensglucosesensor,”
Diabetes Technol. Ther. 8, 312–317 (2006).
20. J. Kottmann, J. M. Rey, and M. W. Sigrist, “New photoacoustic cell design for studying aqueous solutions and
gels,” Rev. Sci. Instrum. 82, 084903 (2011).
21. G. Spanner and R. Niessner, “Noninvasive determination of blood constituents using an array of modulated laser
diodes and a photoacoustic sensor head.” Fresenius J. Anal. Chem. 354, 306–310 (1996).
22. Z. Zhao, “Pulsed photoacoustic techniques and glucose determination in human blood and tissue,” Ph.D. thesis
(University of Oulu, 2002).
23. K. H. Hazen, M. A. Arnold, and G. W. Small, “Measurement of glucose in water ﬁrst-overtone near-infrared
spectra,” Appl. Spectrosc. 52, 1597–1605 (1998).
24. J. T. Olesberg, M. A. Arnold, C. Mermelstein, and J. Schmitz, “Tunable laser diode system for noninvasive blood
glucose measutements.” Appl. Spectrosc. 59, 1480–1484 (2005).
25. J. J. Burmeister and M. A. Arnold, “Evaluation of measurement sites for noninvasive blood glucose sensing with
near-infrared transmission spectroscopy,” Clin. Chem. 45, 1621–1627 (1999).
26. A. Duncan, J. Hannigan, S. S. Freeborn, and H. A. MacKenzie, “A portable non-invasive blood glucose monitor,”
inThe8thInternationalConferenceonSolid-StateSensorsandActuators,1995andEurosensorsIX.Transducers
’95 (1995), pp. 455–458 .
27. H. Ashton, H. A. MacKenzie, P. Rae, Y. C. Shen, S. Spiers, and J. Lindberg, “Blood glucose measurements
by photoacoustics,” in Proceedings of the 10th International Conference on Photoacoustic and Photothermal
Phenomena, Vol. 463 of AIP Conference Proceedings (AIP, 1999), pp. 570–572 .
28. H. A. MacKenzie, H. Ashton, S. Spiers, and Y. Shen, “Advances in photoacoustic noninvasive glucose testing,”
Clin. Chem. 45, 1587–1595 (1999).
29. K. M. Quan, G. B. Christison, H. A. MacKenzie, and P. Hodgson, “Glucose determinaton by a pulsed photoa-
coustic techinque: an experimental study using a gelatin-based tissue phantom.” Phys. Med. Biol. 38, 1911–1922
(1993).
30. H. D. Downing and D. Williams, “Optical constants of water in the infrared,” J. Geophys. Res. 80, 1656–1661
(1975).
31. F. A. Duck, Physical Properties of Tissue (Academic, London, 1990).
32. S. Gebhart, M. Faupel, R. Fowler, C. Kapsner, D. Lincoln, V. McGee, J. Pasqua, L. Steed, M. Wangsness, F. Xu,
and M. Vanstory, “Glucose sensing in transdermal body ﬂuid collected under continuous vacuum pressure via
micropores in the stratum corneum,” Diabetes Technol. Ther. 5, 159–166 (2003).
33. M. Venugopal, K. E. Feuvrel, D. Mongin, and et al., “Clinical evaluation of a novel interstitial ﬂuid sensor system
for remote continuous alcohol monitoring.” IEEE Sensors J. 8, 71–80 (2008).
#161280 - $15.00 USD Received 11 Jan 2012; revised 16 Feb 2012; accepted 17 Feb 2012; published 1 Mar 2012
(C) 2012 OSA 1 April 2012 / Vol. 3,  No. 4 / BIOMEDICAL OPTICS EXPRESS  66834. Y. Huang, , J. Fang, P. Wu, T. Chen, M. Tsai, and Y. Tsai, “Noninvasive glucose monitoring by back diffusion
via skin: chemical and physical enhancements,” Biol. Pharm. Bull. 26, 983–987 (2003).
35. W. Groenendaal, K. A. Schmidt, G. von Basum, N. A. W. van Riel, and P. A. J. Hilbers, “Modeling glucose and
water dynamics in human skin,” Diabetes Technol. Ther. 10, 283–293 (2008).
36. P. Garidel, “Mid-FTIR-microspectroscopy of stratum corneum single cells and stratum corneum tissue,” Phys.
Chem. Chem. Phys. 4, 5671–5677 (2002).
37. K. C. Madison, “Barrier function of the skin: ”La raison d’ˆ etre” of the epidermis,” J. Invest. Dermatol. 121,
231–241 (2003).
38. R. Vonach, “Application of mid-infrared transmission spectrometry to the direct determination of glucose in
whole blood,” Appl. Spectrosc. 52, 820–822 (1998).
39. M. Brandstetter, A. Genner, K. Anic, and B. Lendl, “Tunable external cavity quantum cascade laser for simulta-
neous determination of glucose and lactate in aqueous phase,” Analyst 135, 3260–3265 (2010).
40. G. B. Christison and H. A. MacKenzie, “Laser photoacoustic determination of physiological glucose concentra-
tions in human whole blood,” Med. Biol. Eng. Comput. 31, 284–290 (1993).
41. H. von Lilienfeld-Toal, M. Weidenm¨ uller, A. Xhelaj, and W. M¨ antele, “A novel approch to non-invasive glucose
measurement by mid-infrared spectroscopy: The combination of quantum cascade lasers (QCL) and photoacous-
tic detection,” Vib. Spectrosc. 38, 209–215 (2005).
42. M. Pleitez, H. von Lilienfeld-Toal, and W. M¨ antele, “Infrared spectroscopic analysis of human interstitial ﬂuid
in vitro and in vivo using FT-IR spectroscopy and pulsed quantum cascade lasers (QCL): Establishing a new
approach to non invasive glucose measurement,” Spectrochim. Acta A 85, 61–65 (2012).
43. A. Rosencwaig and A. Gersho, “Theory of photoacoustic effect with solids,” J. Appl. Phys. 47, 64–69 (1976).
44. A. C. Tam, “Applications of photoacoustic sensing techniques,” Rev. Mod. Phys. 58, 381–431 (1986).
45. J. Kottmann, J. M. Rey, and M. W. Sigrist, “New photoacoustic cell with diamond window for mid-infrared
investigations on biological samples,” Proc. SPIE 8223, 82231A (2012).
46. H. G¨ unzler and H. U. Gremlich, IR-Spektroskopie (Wiley-VCH, 2003).
47. R. W. Barry, H. G. M. Edwards, and A. C. Williams, “Fourier transform Raman and infrared vibrational study of
human skin: Assignment of spectral bands,” J. Raman Spectrosc. 23, 641–645 (1992).
48. G. W. Lucassen, G. N. A. van Veen, and J. A. J. Jansen, “Band analysis of hydrated human skin stratum corneum
attenuated total reﬂectance fourier transform infrared spectra in vivo,” J. Biomed. Opt. 3, 267–280 (1998).
49. R. O. Potts, B. G. Guzek, R. R. Harris, and J. E. McKie, “A noninvasive, in vivo technique to quantitatively
measure water concentration of the stratum corneum using attenuated total-reﬂectance Infrared spectroscopy,”
Arch. Dermatol. Res. 277, 489–495 (1985).
50. M. Gloor, G. Hirsch, and U. Willebrand, “On the use of infrared spectroscopy for the in vivo measurement of
the water content of the horny layer after application of dermatologic Ointments,” Arch. Dermatol. Res. 271,
305–313 (1981).
1. Introduction
Diabetes mellitus is a widespread human disease with worldwide 346 million persons
concerned and an estimated 3.4 million deaths due to high blood glucose level per year [1].
Currently no treatment exists or is under development which could possibly cure this illness
in the near future. The therapy of diabetes mellitus so far consists in monitoring the blood
glucose (BG) level of a patient to avoid the danger of hypo- and hyperglycemia and to assist
in adjusting the diet and medical treatment. To monitor the blood sugar level as accurate as
possible frequent measurements are required. Until today this involves puncturing the ﬁngertip
with a lancing device to obtain a drop of blood. The blood sample is placed on a test strip and
usually analyzed via an electrochemical reaction. This expensive procedure is uncomfortable
especially if frequently performed, it bears the risk of infections and does not represent a
continuous measurement technique, which would be ideal for glycemic control [2]. Hence
a non-invasive glucose sensor would greatly increase the quality of life of diabetes patients.
Despite intensive research towards a non-invasive glucose monitoring method since more
than 25 years still no reliable commercial sensor exists, which circumvents the need of blood
sample taking. An overview of the broad research activity and numerous companies involved
in this area is given in review articles [3–6]. Figure 1 summarizes the vast ﬁeld of glucose
measurement techniques and distinguishes three different categories: invasive, minimal
invasive and non-invasive approaches. Optical techniques like polarimetry [7, 8], Raman
spectroscopy [9,10], diffuse reﬂection spectroscopy [11,12], absorption spectroscopy [13–15],
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thermal emission spectroscopy [16,17], ﬂuorescence spectroscopy [18,19] and photoacoustic
(PA) spectroscopy [20–22] have been used to sense glucose with respect to non-invasive
monitoring.
Most of the optical attempts use near-infrared (NIR) light because it can penetrate up to
several mm into human tissue. Unfortunately, glucose absorption in this wavelength region
is weak and interferes strongly with other blood and tissue components [23–25], which
hampered a breakthrough to non-invasive glucose monitoring. Attempts using NIR PA
spectroscopy [21,22,26–29] mainly employ pulsed lasers as excitation sources.
On the contrary, glucose shows strong characteristic absorption and interferes less with other
tissue components in the mid-infrared (MIR) spectral region [5]. However, MIR light only
penetrates up to 100 mm into human skin due to the strong water absorption [30, 31]. As
a consequence glucose has to be sensed within the interstitial ﬂuid (ISF) of the epidermis
since blood capillaries are not reached. Metabolites and proteins diffuse into the ISF on their
way from capillaries to cells. This leads to a strong correlation of BG levels and ISF glucose
concentration within the physiological range as conﬁrmed in clinical trails [32]. In the ISF
small-to-moderate sized molecules, like glucose (or ethanol), are present in the same proportion
as in blood. Hence a frequent calibration with blood measurements is not necessary [33].
The diffusion process leads to a delayed increase of the glucose concentration in the ISF,
which is stated to be between 5 to 15 minutes [13,34]. In general the outer skin layers have a
greater time delay and smaller glucose concentration maxima. Concerning the correlation for
decreasing glucose concentration some uncertainty persists, but there is most likely no time
delay due to the high glucose clearance from epidermal ISF [35]. The outer most layer of the
skin, the stratum corneum (SC) - consisting of cell remains (i.e. dead cells) - acts as a barrier
to protect the human body from mechanical, chemicals or microbiological impacts from the
surrounding [36]. Moreover the SC is responsible to prevent transepidermal water loss. This
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to several mm), has a water content of approximately 10 % [31, 37] and contains marginal
amounts of glucose. Thus in vivo glucose sensing has to involve skin layers deeper than the SC.
For in vitro studies of blood samples or homogeneous tissue phantoms, the penetration depth
is not important since glucose can be detected at the surface. In such experiments glucose
concentrations can be readily tracked using MIR light. Some research groups employed a
quantum cascade laser (QCL) or a FTIR spectrometer to perform transmission measurements
with glucose detection limits of 13.8 mg/dl (in whole blood) [38], 9.4 mg/dl [39] and 4
mg/dl [13] (both in aqueous solution). Unfortunately, these sensitive measurements are hardly
convertible to in vivo sensing and therefore of little beneﬁt to non-invasive glucose sensing.
Guo et al. used wavelength-modulated differential laser photothermal radiometry with two
QCLs at 9.5 and 10.4 mm (i.e., on and off a glucose absorption peak) to measure glucose
concentrations (0 - 440 mg/dl) in an homogeneous aqueous phantom [17]. With a pulsed
CO2 laser and a PA detection Christison et al. measured glucose concentrations in aqueous
solutions and whole-blood (18 - 450 mg/dl) [40]. These two approaches have the potential
of adapting from a laboratory setup to a small-sized portable sensor in the future. However,
both approaches sense glucose concentrations at the sample surface and not in deep epidermal
layers as required for in vivo studies. An attempt to apply MIR PA measurements to in vivo
glucose sensing was recently reported by Lilienfeld-Toal at al. [41,42] but could only indicate
a qualitative correlation between BG and ISF glucose concentration.
We developed a laser PA detection scheme using an external-cavity quantum cascade laser
(tuning range 1010 - 1095 cm−1) as light source and a small-volume PA cell for detection.
This setup bears the potential to shrink from a table size apparatus to a handheld device. When
investigating epidermal skin samples having a high water content, challenges are the detection
of a weak PA signal due to glucose on a strong water background and humidity variations in
the PA chamber due to the evaporation of water. To stabilize the conditions in the PA chamber
(i.e., to maintain a constant relative humidity) for sensitive measurements, a constant N2 ﬂow
is applied to ventilate the cell. Here we report on the performance of this setup by measuring
glucose concentration changes through the SC in human epidermis in vitro. This is a signiﬁcant
step compared to former measurements since it demonstrates the tracking of glucose by MIR
light not only at the surface but in lower epidermal skin layers. Furthermore by tuning the QCL
a spectrum of human epidermis with and without the presence of glucose could be recorded.
2. Photoacoustic signal generation
The PA signal generation in solid samples has been described mathematically ﬁrst by
Rosencwaig and Gersho. Using an indirect PA detection, namely a detection of the generated
PA signal in a strongly absorbing solid in a gas-ﬁlled PA chamber adjacent to the solid surface
is described by their thermal piston model [43]. Depending on the optical and thermal proper-
ties of the solid sample with respect to its length l, this model distinguishes six different cases.
The most important case for our application (l > ma > ms) is pictured in Fig. 2. Here ma = 1/a
denotes the absorption length in the sample (a: absorption coefﬁcient at the employed wave-
length l), ms =
q
Ds
p f denotes the thermal diffusion length with the thermal diffusivity Ds and
the modulation frequency f of the incident radiation. Hence the thermal diffusion length ms can
be controlled by f.
For our case (l > ma > ms) the PA signal amplitude APA is given by [44]
APA ≈
g  P0 Ds 
p
Dg r2
√
p  T0 ks
 
I0 a
V0  f
3
2
, (1)
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Rosencwaig Gersho model. lg denotes the length of the gas-ﬁlled PA chamber, l the sample
length, ma=1/a the optical absorption length and ms the thermal diffusion length. In this
ﬁgure a length ratio of l > ma > ms is pictured, as occurring in the samples investigated in
this work. The periodical PA signal is detected with a microphone (Mic).
where g=Cp/Cv is the ratio of speciﬁc heats of the coupling gas at constant pressure and vol-
ume, P0 and T0 are the ambient pressure and temperature, respectively, I0 is the incident laser
intensity (beam radius r), Dg is the thermal diffusivity of the coupling gas, ks the thermal con-
ductivity of the solid andV0 the volume of the PA cell.
According to Eq. (1) a temperature change in the PA chamber directly translates to a 1/T0-
dependence of the generated pressure amplitude APA. A variation of the relative humidity (RH)
in the coupling gas, however, only indirectly inﬂuences the PA signal via Dg. At room tempera-
ture a coupling gas exchange from water-saturated air to pure N2 causes an estimated increase
of Dg of 5.3 %, i.e., of APA of 28 %, whereas a change from dry air to a pure N2 atmosphere
causes an increase of APA by only 2.8 %. The variation of the speciﬁc heat ratio g by a change
of the composition of the coupling gas can be neglected as it contributes <1% to the total sig-
nal change. At higher RH the scattering and the absorption of light in the coupling gas might
also increase. However, these contributions depend strongly on the cell geometry - particularly
the length of the gas-ﬁlled PA chamber lg (see Fig. 2) and the microphone position - and the
excitation wavelength.
For a biological sample like human skin considered here, which is characterized by a high water
content, the penetration of MIR light is small due to the strong water absorption in this wave-
length region. Hence the sample length l is usually larger than the optical penetration depth
ma (i.e., l > ma). By adjusting the modulation frequency f one can vary the thermal diffusion
length of the sample ms and restrict the discussion to the case where Eq. (1) holds. Hence, the
signal amplitude APA recorded in the PA cell with a microphone shows the dependence
APA µ
I0 a
V0  f
3
2
, (2)
i.e., the PA signal directly scales with the incident intensity and the absorption coefﬁcient of
the sample.
3. Experimental setup
The PA setup is pictured in Fig. 3. An external-cavity quantum cascade laser (EC-QCL) (Day-
light Solutions DLS-TLS-001-PL) is employed as excitation source. The EC-QCL is tunable in
0.9 cm−1 wavenumber steps from 1010 - 1095 cm−1 via the external grating. Fine tuning can
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ping mirror, L = lens, I = Iris, DL = diode laser (for alignment tasks), CHOP = chopper,
PM = power meter, MIC= microphone and RH-T = relative humidity-temperature sensor.
be obtained by changing the temperature of the QCL chip. The QCL covers a range of glucose
absorption in the MIR, with two strong absorption peaks at 1034 and 1080 cm−1. The maximal
average laser power lies between 20 mW (at 1010 cm−1) and 130 mW (at 1055 cm−1) depend-
ing on the emission wavelength. Normally the sample was irradiated with 30 to 40 mW average
power during measurements. A mechanical chopper (New Focus Model 3501) modulates the
continuous-wave (cw) laser light, which is focused by several anti-reﬂection coated ZnSe lenses
into the PA cell. The beam passes the PA chamber and is absorbed in the sample sealing the
cell. This leads to the generation of an acoustic wave in the coupling gas which is sensed with
an electret microphone (Knowles FG-23329-P07). The microphone has a diameter of only 2.59
mm, a ﬂat frequency response from 100 Hz to 10 kHz and a sensitivity of 53 dB (relative to 1.0
V/0.1 Pa). The small microphone diameter allows a compact cell design with a small volume
V0 which is favorable in terms of signal amplitude (see Eq. (2)) and sensor size. The detected
PA signal is pre-ampliﬁed and measured with a lock-in ampliﬁer (Stanford Research SR830)
before being stored in a computer. The temperature and the RH are recorded simultaneously
with a simple sensor (Sensirion SHT21, 3 mm x 3 mm x 1.1 mm) with an accuracy of ± 0.4 K
and ± 3 %, respectively, to monitor the conditions inside the PA chamber.
3.1. Photoacoustic cell design
A special PA cell which allows measurements on human skin samples in contact with aqueous
glucose solution has been developed. The transversal cross section of the PA cell with the
attached sample and reservoir for liquids is depicted in Fig. 4. The PA cell and the sample
reservoir are constructed out of a copper block (4 x 25 x 35 mm). The PA chamber has a
volumeV of only 78.5 mm3 (radius r = 2.5 mm and h = 4 mm), is polished and gold-coated on
the inner surface to minimize spurious PA signals due to absorption on the cell walls. The laser
beam passes perpendicularly through an anti-reﬂection coated ZnSe window, which seals the
PA cell on the bottom side. The ZnSe window is pressed on a thin rubber sheet into which two
thin needles (length = 19 mm and inner diameter = 0.4 mm) have been introduced. One of the
needles is connected via silicon tubes to a mass ﬂow controller (MKS Instruments, Multi Gas
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closed directly by the sample itself (i.e., human skin sample). N2 ventilation is needed, if
the PA chamber is closed with a sample containing volatile components.
Controller 647B) providing a constant ﬂow of N2 to the cell. The other needle is left open. This
guarantees stable conditions in the PA chamber, necessary for precise measurements. At half
height the microphone and the temperature and RH sensor are connected through cylindrical
holes (length = 1 mm, diameter = 1 mm) to the PA chamber. On the sample side the PA chamber
is separated from the reservoir for liquids by a 70 - 100 mm thick human epidermal skin sample.
To allow measurements of other samples, which do not provide a rigid closure of the PA cell
or if measuring without N2 ventilation is preferred, the cell can be sealed with a thin chemical
vapor deposition (CVD) diamond window (Diamond Materials). The diamond window assures
stable conditions in the PA chamber and due to the favorable thermal and optical properties of
diamond strong PA signals of the sample are obtained. A detailed description of the diamond-
window closed cell can be found elsewhere [20,45].
3.2. Preparation of epidermal skin sample
Epidermal sheets were isolated from forskins obtained from the University Childrens Hospi-
tal of Zurich after routine circumcisions. All patients (and/or their parents) gave their written
consent for this study in accordance with the Ethics Commission of the Canton Zurich (noti-
ﬁcation no. StV-12/06). Foreskins were cut into approximately 2 cm2 pieces and digested for
15-18 hours at 4◦C in 12 U/ml dispase in Hanks buffered salt solution containing 5 mg/ml
gentamycin. Thereafter, the epidermis and the dermis could be easily separated using forceps.
Epidermal sheets were stored in a transport medium (DMEM with 1% penicillin/streptomycin)
until further application.
4. Results and Discussion
4.1. RH dependence in PA measurements
If biological samples with a high water content are investigated with an open-ended PA cell
the evaporation of water causes a steady increase in RH until saturation is reached. This results
in water condensation within the PA chamber and makes sensitive measurements impossible.
In Fig. 5 the RH evolution in the PA chamber during a measurement without laser irradiation
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mal skin sample. In the open-ended PA cell (solid line) the RH constantly increases, until
it ﬁnally leads to condensation. With N2 ventilation the RH decreases below 20 % and
stabilizes.
of an epidermal skin sample is shown. Even though the SC has a low permeability for water,
the RH reaches a level of over 70 % within less than 10 min and still rises further. With
laser irradiation the RH increase is even more pronounced [20]. In vivo this process is even
accelerated due to the transpiration of the human body. If a constant N2 ﬂow (10 standard cubic
centimeters per minute (sccm)) is applied to the PA chamber the RH falls within 2 min to less
than 20 % and stabilizes at a low level (see Fig. 5).
The N2 ventilation causes an increase of the pressure in the PA chamber. For N2 ﬂow rates
between 0 and 40 sccm the pressure dependence is linear. At atmospheric pressure a 10 sccm
rise in the ﬂow rate results in an approximately 1 % increase in the PA signal amplitude, which
has to be taken into account for quantitative measurements.
4.2. Diffusion of glucose into epidermal skin
For the investigation of glucose penetration into epidermal skin the PA chamber is directly
closed with the skin sample (see Fig. 4). The epidermal skin is ﬁxed on the cell with the stratum
corneum towards the PA chamber and the liquid reservoir placed on the lower epidermal layers.
To induce varying glucose concentration in the epidermal skin sample, differently concentrated
solutions (i.e., D-(+)-glucose (Sigma Aldrich) dissolved in distilled water) were placed in the
sample reservoir (see Fig. 4). The lower epidermal skin layers are in direct contact with the
solution. Like in vivo, an exchange of constituents (here mainly water and glucose) occurs
through passive diffusion. In Fig. 6 consecutive PA measurements using different glucose
concentrations are shown. The measurements were performed at 1034 cm−1 (absorption peak
of glucose) with a modulation frequency of 137 Hz, 30 mW average power and an integration
time of 1 s. Each time the sample solution was exchanged, the laser beam was blocked and
the PA signal fell to zero. Immediately after replacing the sample solution the shutter was
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glucose concentration. During sample exchange, the laser beam was blocked, which leads
to the sharp signal decrease. The arrows mark positions where the glucose concentration of
the consecutive sample solution was increased by 1 g/dl compared to the previous one. The
inset implies that a time of approximately 90 s is necessary to establish a stable glucose
concentration proﬁle within the epidermal skin sample.
reopened. The arrows (numbered 1) - 3)) indicate a 1 g/dl increase of the glucose concentration
of the consecutive samples. For higher concentration the PA signal is larger as expected but
after increasing the concentration, approximately 90 seconds are needed to reach a stable signal
as can be seen in the inset of Fig. 6. This is due to the time the glucose needs to diffuse from
the sample solution into the epidermal skin. It indicates that the time delay between BG and
ISF glucose concentration in vivo should be small (5 -15 min as stated in literature [13,34]).
Once a steady glucose concentration proﬁle is obtained within the epidermal skin sample a
stable PA signal is measured.
If the glucose concentration is increased shortly after reopening the shutter the PA signal is
still on the same level as before, which shows that the signal contribution from the glucose
solution itself is negligibly small. A rough estimation of the optical penetration depth of skin at
1034 cm−1 - assuming water to be the main absorbing component with a 10 % water content in
a 20 mm thick SC and a 60 % water content in the lower epidermal layer - yields 45 mm. This
is an upper limit of the penetration since other absorbing components have been neglected.
It conﬁrms that the generated PA signal almost entirely originates from the epidermal skin
sample (70 - 100 mm thick) and not from the underlying glucose solution (i.e., l > ma > ms as
required for Eq. (2)).
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According to the procedure described in section 4.2 different glucose concentrations were
generated in the epidermal skin sample. In Fig. 7 a) the dependence of the PA signal on
glucose concentration in the epidermal skin sample is pictured. The data points 2 - 7 (i.e., up
to 3 g/dl) correspond to the signals displayed in Fig. 6 and were obtained after averaging for
each sample solution. A low modulation frequency (i.e., 137 Hz) was chosen to ensure a long
thermal diffusion length to access not only optical but also thermal information from deeper
skin layers (see Section 2). The PA signal linearly depends on the glucose concentration within
the large concentration range of 0 to 10 g/dl, indicating that even for the highest concentration
the requirements for Eq. (2) (i.e., l > ma > ms) still hold. This would not be the case in pure
water since the optical absorption length for water is 17 mm (absorption coefﬁcient of water
at 1034 cm−1: a1034 = 590 cm−1) which is smaller than its thermal diffusion length for a
modulation frequency of 137 Hz (ms = 19 mm) even without added glucose. Due to a water
content of only 10 % in the SC and of approximately 60 % in the other epidermal layers the
optical absorption length might be up to 45 mm as discussed in section 4.2, resulting in the
observed linear dependence of the PA signal on the glucose concentration.
The RH and the temperature in the PA chamber were monitored simultaneously with the
Fig. 7. a) PA signal dependence on glucose concentration in a human epidermal skin sam-
ple (0 - 10 g/dl). A simultaneous measurement of RH (•) and temperature (+) allows to
compensate PA signal changes due to a variation of these parameters. Compensation for
these drifts leads to an improved correlation between the PA signal and the glucose con-
centration (R2=0.998). b) PA signal dependence on glucose concentration in a human epi-
dermal skin sample for lower concentrations (0 - 2000 mg/dl).
measurement of the PA signal as shown in Fig. 7 a). Thanks to the N2 ventilation variations
in RH are small. Nevertheless ﬂuctuations occur especially when long time measurements are
performed. Recording the RH and temperature enables to compensate PA signal amplitude
ﬂuctuations caused by a variation of these parameters (see Section 2). Since the PA cell length
is rather short (i.e., 4 mm) and the water-vapor absorption within the tuning range of the
QCL is weak (except at 1066 cm−1) the contribution of the gas absorption is negligible. If
the level of RH is well below saturation the effect of MIR scattered light around 10 mm is
small especially since the microphone is connected via a tube with the PA chamber. For the
PA cell geometry used in this work a somewhat larger PA signal increase with increasing RH
is experimentally observed compared to the one predicted solely from the parameter change of
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the correlation between the PA signal and the glucose concentration leading to a R2 of 0.998
(see Fig. 7 a)) .
Figure 7 b) shows PA signals for lower glucose concentration (0 - 2000 mg/dl), i.e., including
the physiological range of 30 - 500 mg/dl. The error-bars correspond to twice the standard
deviation (± s) using a lock-in integration time of 1 s. This yields a detection limit for glucose
in epidermal skin samples of 100 mg/dl with signal-to-noise ratio (SNR) of 1. The detection
limit is not restricted by the sensitivity of the PA device itself as previous measurements
imply [20] but mainly caused by the mechanical instability of the thin epidermis. A small
pressure change in the PA chamber or a variation of the liquid amount in the reservoir alters
the position of the epidermis slightly (i.e., upwards or downwards bending) and causes
ﬂuctuations in the generated PA signal. Once the solution is placed in the reservoir the PA
signal ﬂuctuations are very small. Only for long time measurements during which a signiﬁcant
part of the water evaporates into the surrounding and hence alters the water amount in the
reservoir, drifts of the PA signal are observed. These measurements demonstrate the ability of
the MIR PA technique to detect glucose within deep epidermal skin layers.
4.4. Spectra of epidermal skin samples
The tuning capability of the EC-QCL enables the recording of a PA spectrum from 1010 to
1095 cm−1. This covers two strong glucose absorption peaks at 1034 and 1080 cm−1. When
tuning the EC-QCL by rotating the grating, the cavity length is not maintained and mode-hops
occur approximately every 0.9 cm−1. Fine tuning is obtained by adjusting the temperature of
the QCL chip with a thermoelectric cooler.
For the measurements pictured in Fig. 8 a) distilled water, 2 g/dl and 10 g/dl aqueous glucose
solutions were successively placed in the liquid reservoir. After the completion of the diffusion
process a stable PA signal was obtained. The EC-QCL was then tuned via the external grating
Fig. 8. a) PA spectrum of a human epidermal skin sample in contact with water x, 2 g/dl
(+) and 10 g/dl glucose solution (•). b) PA spectrum of different glucose concentrations (2
and 10 g/dl) in human epidermal skin samples with subtracted water and skin background.
A comparison of a FTIR attenuated total reﬂection spectrum of glucose shows a good
correlation with the PA measurement.
in steps of 1 cm−1 to record a PA spectrum. Due to the wavelength-dependent QCL output in-
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water shows four unresolved absorption peaks at 1032, 1048, 1052 and 1076 cm−1. In the 1010
to 1095 cm−1 ﬁngerprint region covered by the QCL nucleic acids, carbohydrated lipids and
proteins show characteristic C-O-P, C-O-C and C-C vibrations [46]. By comparing the meas-
ured peak positions to the FTIR spectra of SC reported by Garidel [36] the absorption peak at
1076 cm−1 can be assigned to the symmetric PO−
2 stretch between 1070 - 1080 cm−1. Its exact
position signiﬁcantly depends on the presence of cations and hydration effects. Additional IR
contributions arise from the n(CC) skeletal trans conformation (1077 cm−1) and cis confor-
mation (1032 cm−1) [47,48]. The double peaks at 1048 and 1052 cm−1 might be caused by a
C-OP stretch (1047 cm−1 [36]) and albumin absorption (1052 cm−1 [42]). However the exact
assignment of the vibrational modes is difﬁcult since in literature the focus usually lies on the
stronger absorption peaks like the amide I and amide II absorption at 1650 and 1550 cm−1,
respectively, which can be used for example to determine the water content of the SC [49,50].
The subtraction of the pure water and epidermal skin spectrum from the spectra with 2 and
10 g/dl glucose in Fig. 8 a) reveals the glucose spectrum with its two prominent absorption
peaks at 1034 and 1080 cm−1 (see Fig. 8 b)). For comparison a FTIR attenuated total reﬂec-
tion (ATR) spectrum of a corresponding glucose solution (with subtracted water background)
recorded with a resolution of 1 cm−1 is pictured in Fig. 8 b). This shows good agreement with
the PA spectrum and demonstrates the possibility of recording a glucose spectrum in a human
epidermal skin sample.
5. Conclusion
The N2 ventilated PA cell has proven to provide stable measurement conditions for the investi-
gation of biological samples with high water content. Measurements on human epidermal skin
samples showed that RH decreases within less than 2 min from room RH to below 20 %.
Different glucose concentrations were generated in the epidermal skin sample by passive dif-
fusion from a glucose solution in contact with the lower epidermal layers. This process takes
approximately 90 s, which conﬁrms that in in vivo measurements a short time delay between
BG and ISF glucose concentration is expected. Due to the construction of the human epider-
mis the outer most layer, the SC, contains negligible glucose concentrations. Hence by placing
the PA cell on the SC it is necessary to measure glucose through the 10 - 20 mm thick SC.
Our PA setup is able to sense glucose through the SC in the lower epidermal skin layers with
a detection limit of 100 mg/dl (SNR=1). It is currently limited by the mechanical stability of
the thin skin sample (<100 mm). These measurements represent a signiﬁcant step towards in
vivo glucose sensing since they prove the feasibility of tracking glucose in vitro within lower
epidermal layers despite the limited penetration depth of MIR light into human skin. Epidermal
skin samples as used in our study match in vivo conditions rather well and the measurements
thus demonstrate that possible spectral interferences with other epidermal constituents do not
signiﬁcantly disturb the glucose detection.
The obtained detection limit of glucose in epidermal skin lies within the physiological range
(30 - 500 mg/dl) but is still too high for in vivo glucose monitoring of diabetes patients. For in
vivo measurements the sensor has to be placed directly on the human skin which then provides
a rigid seal of the PA cell. A lower detection could thus be expected. Earlier measurements with
a similar PA cell yielded a detection limit of 33 mg/dl (SNR=1) yet in aqueous solutions [20]. If
this detection limit of glucose could be reached in vivo the sensitivity would be very close to the
±20 mg/dl accuracy needed for an FDA approval of the sensor. However,in vivo measurements
bear additional problems caused by blood pulsation, movements of the patient or different skin
types which renders in vivo glucose sensing more challenging. First in vivo measurements with
the presented sensor showed, in addition to the laser-induced PA signal, a periodic signal caused
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in integration times (∼ 3 ms) are employed. Since lock-in integrations times of typically 1 s are
used for glucose sensing, blood pulsation only minimally affects the measurements.
To improve the current glucose detection limit of the sensor simple measurements using a refer-
ence wavelength (i.e., with no glucose absorption) or an out-of-phase excitation at a reference
wavelength could be envisaged. Both approaches reduce problems caused by long-term drift
whereas the second technique - successfully employed in photothermal radiometry [17] - also
eliminates the large inherent background signal from the sample itself.
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